Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects.
The significance of catalytic autoantibodies abzymes in the pathogenesis of multiple sclerosis was evaluated in patients with different disease patterns and severity of disability.
Misikov
V K
VK
Moscow Regional Research and Clinical Institute, Moscow, Russia.
Kimova
M V
MV
Durova
O M
OM
Gabibov
A G
AG
Suchkov
S V
SV
Vorobev
I I
II
Ponomarenko
N A
NA
D000328:Adult; D017151:Antibodies, Catalytic / Q000097:blood* / Q000134:cerebrospinal fluid; D001323:Autoantibodies / Q000097:blood* / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000097:blood / Q000175:diagnosis* / Q000276:immunology; D004676:Myelin Basic Protein / Q000276:immunology*; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein / Q000276:immunology*; D063308:Myelin-Oligodendrocyte Glycoprotein
D017151:Antibodies, Catalytic; D001323:Autoantibodies; C571326:MOG protein, human; D004676:Myelin Basic Protein; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein